Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Fitzgerald

Showing results (551-560 of 629) with videos related to

Pageof 63
Sort By:
The European Respiratory Journal|September 21, 2019
The effects of marijuana smoking on lung function in older peopleWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 6, 2019
Acceptability of Standardized EEG Reporting in an Electronic Health RecordStephanie Witzman, Shavonne L Massey, Sudha Kessler, et al.
The European Respiratory Journal|April 18, 2020
Population-based case-finding to identify subjects with undiagnosed asthma or COPDMatthew Preteroti, G Alex Whitmore, Katherine L Vandemheen, et al.
Respirology (Carlton, Vic.)|February 18, 2020
Identification and definition of asthma-COPD overlap: The CanCOLD studyMiriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
The European Respiratory Journal|June 29, 2019
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescentsHelen K Reddel, J Mark FitzGerald, Eric D Bateman, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Plos One|August 16, 2016
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass SpectrometryJanice M Leung, Virginia Chen, Zsuzsanna Hollander, et al.
BMJ Open|June 17, 2017
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trialMatshediso C Mokoka, Lorna Lombard, Elaine M MacHale, et al.
Pageof 63

Showing results (551-560 of 629) with videos related to

Sort By:
Pageof 63
The European Respiratory Journal|September 21, 2019
The effects of marijuana smoking on lung function in older peopleWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 6, 2019
Acceptability of Standardized EEG Reporting in an Electronic Health RecordStephanie Witzman, Shavonne L Massey, Sudha Kessler, et al.
The European Respiratory Journal|April 18, 2020
Population-based case-finding to identify subjects with undiagnosed asthma or COPDMatthew Preteroti, G Alex Whitmore, Katherine L Vandemheen, et al.
Respirology (Carlton, Vic.)|February 18, 2020
Identification and definition of asthma-COPD overlap: The CanCOLD studyMiriam Barrecheguren, Lancelot Pinto, Seyed-Mohammad-Yousof Mostafavi-Pour-Manshadi, et al.
The European Respiratory Journal|June 29, 2019
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescentsHelen K Reddel, J Mark FitzGerald, Eric D Bateman, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2021
A Method for Determining the Kinetics of Small-Molecule-Induced UbiquitinationEllen F Vieux, Roman V Agafonov, Lydia Emerson, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Plos One|August 16, 2016
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass SpectrometryJanice M Leung, Virginia Chen, Zsuzsanna Hollander, et al.
BMJ Open|June 17, 2017
In patients with severe uncontrolled asthma, does knowledge of adherence and inhaler technique using electronic monitoring improve clinical decision making? A protocol for a randomised controlled trialMatshediso C Mokoka, Lorna Lombard, Elaine M MacHale, et al.
Pageof 63